Showing promise in the arena of weight management treatment, retatrutide is a distinct method. Different from many existing medications, retatrutide works as a dual agonist, concurrently affecting both GLP-like peptide-1 (GLP-1) and glucose-responsive insulinotropic substance (GIP) receptors. The dual activation promotes multiple advantageous effec